Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer

Jan 4, 2017

Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results

Dec 6, 2016

Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting

Nov 30, 2016

Heat Biologics to Present Topline HS-110/Nivolumab Combination Phase Ib Lung Cancer Results at the International Society for the Study of Lung Cancer Annual Meeting

Nov 17, 2016

Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at the Society of Urological Oncology Annual Meeting

Nov 16, 2016

Heat Biologics Presents ComPACT Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting

Nov 14, 2016

Heat Biologics Provides Corporate Update and Reports Third Quarter 2016 Financial Results

Nov 10, 2016

Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 7, 2016

Heat Biologics and University of Miami Announce Zika Vaccine Collaboration

Oct 25, 2016

Heat Biologics to Present at Two Upcoming Investor Conferences and Panel Discussion

Oct 17, 2016